Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00433914
Status:
COMPLETED
Last Update Posted:
2015-03-06
First Post:
2007-02-09
Brief Title:
Safety Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine When Administered to Healthy Infants
Sponsor:
Novartis Vaccines
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02
Start Date Type:
None
Primary Completion Date:
2007-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-07
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-09
First Submit QC Date:
February 9 2007
Study First Post Date:
2007-02-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2015-03-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-05
Last Update Post Date:
2015-03-06
Last Update Post Date Type:
ESTIMATED